The year 2024 marked the 50-years anniversary of the Expanded Programme on Immunization: over 150 million lives have been saved over these past 50 years and 40% of the reduction in infant deaths globally has been due to vaccination. Despite important progress in some areas, there is widespread concern in the immunization community that childhood immunization coverage levels have been stalling for many years now, leaving many children unprotected year after year.

Understanding vaccine markets is a key input to increasing access to vaccines and a critical component to improving immunization coverage. The 2024 GVMR provides a snapshot of vaccine markets globally in 2023, covering 88 vaccine products sold in 207 countries and procurement channels by 116 manufacturers.  The report analyses market trends between different country income groups and regions and over time using historical data, to support an improved understanding of individual vaccine markets as well as cross-cutting issues. The insights from this report provide valuable market intelligence to governments, industry, global public health agencies, and other key decision-makers. It helps identify challenges and opportunities to accelerate equitable access to vaccines worldwide, aligning with the Call to Action issued in the 2022 GVMR, which remains highly relevant today.

Report by the World Health Organization